Literature DB >> 17359383

Pollen-induced airway inflammation, hyper-responsiveness and apoptosis in a murine model of allergy.

L Conejero1, Y Higaki, M L Baeza, M Fernández, I Varela-Nieto, J M Zubeldia.   

Abstract

BACKGROUND: Previous studies indicate that murine models are useful tools for studying the allergic diseases, including certain aspects of bronchial asthma such as cellular tissue inflammation and pulmonary function.
OBJECTIVE: To develop an experimental model of allergic lung inflammation based on a relevant human allergen, olive pollen, and to establish the immunological, cellular and functional airway features of the allergic response in this model.
METHODS: Induction of systemic allergic response was achieved by the subcutaneous administration of Olea europaea extract in BALB/c mice. Olea-specific Igs (IgG1, IgG2a and IgE) and cytokines from splenocyte cultures IL-4, IL-5 IL-10, IL-13 and IFN-gamma were measured. Allergic airway response was generated by transnasal instillation of the allergens. Airway responsiveness was monitored by non-invasive methacholine inhalation challenge. Lungs were paraffin embedded and histologically analysed. Apoptosis was studied by the TUNEL technique in the lung tissue and through cell cycle analysis by flow cytometry in splenocytes.
RESULTS: Our results demonstrate that Olea-sensitized mice develop a specific allergic antibody (IgG1 and IgE) and cytokine (IL-4, IL-5, IL-10 and IL-13) response. After transnasal Olea instillation, they show inflammatory infiltration of lung tissue, mucus secretion and non-specific hyper-responsiveness in the airway. Concomitantly, differences in the rate of apoptosis are observed in the lung cells as well as a significant reduction of spontaneous apoptosis in the splenocytes of allergic mice.
CONCLUSION: We present a novel animal model of olive pollen-allergic disease. This model presents traits associated with human allergic asthma and could be an interesting tool in the study of underlying molecular mechanisms and in exploring the therapeutic approaches to this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359383     DOI: 10.1111/j.1365-2222.2007.02660.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  5 in total

1.  Artemisia sieversiana pollen allergy and immunotherapy in mice.

Authors:  Qian Zhang; Guangpeng Xi; Jia Yin
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Assessment of airway distribution of transnasal solutions in mice by PET/CT imaging.

Authors:  M L Soto-Montenegro; L Conejero; J J Vaquero; M L Baeza; J M Zubeldia; M Desco
Journal:  Mol Imaging Biol       Date:  2009-04-02       Impact factor: 3.488

3.  Specific panallergen peptide of Sorghum Polcalcin showing IgE response identified based on in silico and in vivo peptide mapping.

Authors:  Chandra Sekhar Bokka; Ganesh Kumar Veeramachaneni; V B S C Thunuguntla; Naresh Kumar Manda; Jayakumar Singh Bondili
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

4.  Impact on allergic immune response after treatment with vitamin A.

Authors:  Victor Matheu; Karin Berggård; Yvelise Barrios; Ysamar Barrios; Maria-Rosa Arnau; Jose M Zubeldia; Maria L Baeza; Ove Back; Shohreh Issazadeh-Navikas
Journal:  Nutr Metab (Lond)       Date:  2009-10-23       Impact factor: 4.169

5.  Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

Authors:  Lucie Mondoulet; Vincent Dioszeghy; Mélanie Ligouis; Véronique Dhelft; Emilie Puteaux; Christophe Dupont; Pierre-Henri Benhamou
Journal:  ISRN Allergy       Date:  2012-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.